# Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

> **NCT04084665** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Rockefeller University**

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Guselkumab

## Key facts

- **NCT ID:** NCT04084665
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-06-01
- **Primary completion:** 2020-07-30
- **Final completion:** 2020-07-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** COVID-19 Pandemic
- **Last updated:** 2020-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04084665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04084665, "Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04084665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*